Cardiac injection of USSC boosts remuscularization of the infarcted heart by shaping the T-cell response

J Mol Cell Cardiol. 2023 Feb:175:29-43. doi: 10.1016/j.yjmcc.2022.11.006. Epub 2022 Dec 6.

Abstract

Regenerating the injured heart remains one of the most vexing challenges in cardiovascular medicine. Cell therapy has shown potential for treatment of myocardial infarction, but low cell retention so far has limited its success. Here we show that intramyocardial injection of highly apoptosis-resistant unrestricted somatic stem cells (USSC) into infarcted rat hearts resulted in an unprecedented thickening of the left ventricular wall with cTnT+/BrdU+ cardiomyocytes that was paralleled by progressively restored ejection fraction. USSC induced significant T-cell enrichment in ischemic tissue with enhanced expression of T-cell related cytokines. Inhibition of T-cell activation by anti-CD28 monoclonal antibody, fully abolished the regenerative response which was restored by adoptive T-cell transfer. Secretome analysis of USSC and lineage tracing studies suggest that USSC secrete paracrine factors over an extended period of time which boosts a T-cell driven endogenous regenerative response mainly from adult cardiomyocytes.

Keywords: Cardiac regeneration; Cell therapy; Fibroblasts; Paracrine factors; T-cells; USSC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult Stem Cells*
  • Animals
  • Cytokines
  • Myocardial Infarction* / therapy
  • Myocytes, Cardiac
  • Rats
  • T-Lymphocytes

Substances

  • Cytokines